CHD1L: a novel oncogene

来自 EBSCO

阅读量:

67

作者:

W ChengY SuF Xu

展开

摘要:

Comprehensive sequencing efforts have revealed the genomic landscapes of common forms of human cancer and~140 driver genes have been identified, but not all of them have been extensively investigated.CHD1L(chromodomain helicase/ATPase DNA binding protein 1-like gene) or ALC1 (amplified in liver cancer 1) is a newly identified oncogene located at Chr1q21 and it is amplified in many solid tumors. Functional studies of CHD1L in hepatocellular carcinoma and other tumors strongly suggested that its oncogenic role in tumorigenesis is through unleashed cell proliferation, G1/S transition and inhibition of apoptosis. The underlying mechanisms of CHD1L activation may disrupt the cell death program via binding the apoptotic protein Nur77 or through activation of the AKT pathway by up-regulation of CHD1L-mediated target genes (e.g., ARHGEF9, SPOCK1 or TCTP). CHD1L is now considered to be a novel independent biomarker for progression, prognosis and survival in several solid tumors. The accumulated knowledge about its functions will provide a focus to search for targeted treatment in specific subtypes of tumors.

展开

DOI:

10.1186/1476-4598-12-170

被引量:

48

年份:

2013

通过文献互助平台发起求助,成功后即可免费获取论文全文。

相似文献

参考文献

引证文献

来源期刊

Molecular Cancer
20130000

引用走势

2017
被引量:11

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用